These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 25872028)
21. Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure. Buermans HP; Redout EM; Schiel AE; Musters RJ; Zuidwijk M; Eijk PP; van Hardeveld C; Kasanmoentalib S; Visser FC; Ylstra B; Simonides WS Physiol Genomics; 2005 May; 21(3):314-23. PubMed ID: 15728335 [TBL] [Abstract][Full Text] [Related]
22. In vivo Electrophysiological Study of Induced Ventricular Tachycardia in Intact Rat Model of Chronic Ischemic Heart Failure. Weigand K; Witte R; Moukabary T; Chinyere I; Lancaster J; Pierce MK; Goldman S; Juneman E IEEE Trans Biomed Eng; 2017 Jun; 64(6):1393-1399. PubMed ID: 27608446 [TBL] [Abstract][Full Text] [Related]
23. Arrhythmogenic right ventricular dysplasia. Fontaine G Curr Opin Cardiol; 1995 Jan; 10(1):16-20. PubMed ID: 7787258 [TBL] [Abstract][Full Text] [Related]
24. Electrical and mechanical alternans during ventricular tachycardia with moderate chronic heart failure. Chinyere IR; Moukabary T; Goldman S; Juneman E J Electrocardiol; 2018; 51(1):33-37. PubMed ID: 29129349 [TBL] [Abstract][Full Text] [Related]
25. Transmural dispersion of repolarization and cardiac remodeling in ventricles of rabbit with right ventricular hypertrophy. Meedech P; Saengklub N; Limprasutr V; Kalandakanond-Thongsong S; Kijtawornrat A; Hamlin RL J Pharmacol Toxicol Methods; 2015; 71():129-36. PubMed ID: 25305588 [TBL] [Abstract][Full Text] [Related]
26. Aldosterone blockade attenuates development of an electrophysiological substrate associated with ventricular tachyarrhythmias in heart failure. Stambler BS; Laurita KR; Shroff SC; Hoeker G; Martovitz NL Heart Rhythm; 2009 Jun; 6(6):776-83. PubMed ID: 19427273 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of suspected right ventricular pathology in the athlete. Sniderman JD; Sado DM; Sniderman AD; McKenna WJ Prog Cardiovasc Dis; 2012; 54(5):397-406. PubMed ID: 22386290 [TBL] [Abstract][Full Text] [Related]
28. Reversible pulmonary trunk banding. II. An experimental model for rapid pulmonary ventricular hypertrophy. Dias CA; Assad RS; Caneo LF; Abduch MC; Aiello VD; Dias AR; Marcial MB; Oliveira SA J Thorac Cardiovasc Surg; 2002 Nov; 124(5):999-1006. PubMed ID: 12407385 [TBL] [Abstract][Full Text] [Related]
29. Provocation of an autoimmune response to cardiac voltage-gated sodium channel NaV1.5 induces cardiac conduction defects in rats. Korkmaz S; Zitron E; Bangert A; Seyler C; Li S; Hegedüs P; Scherer D; Li J; Fink T; Schweizer PA; Giannitsis E; Karck M; Szabó G; Katus HA; Kaya Z J Am Coll Cardiol; 2013 Jul; 62(4):340-9. PubMed ID: 23684688 [TBL] [Abstract][Full Text] [Related]
30. Analysis of the arrhythmogenic substrate in human heart failure. Partemi S; Batlle M; Berne P; Berruezo A; Campos B; Mont L; Riuró H; Roig E; Pérez-Villa F; Ortiz J; Pascali VL; Oliva A; Brugada R; Brugada J Cardiovasc Pathol; 2013; 22(2):133-40. PubMed ID: 23036686 [TBL] [Abstract][Full Text] [Related]
31. Ventricular repolarization in a rat model of global heart failure. Krandycheva V; Kharin S; Strelkova M; Shumikhin K; Sobolev A; Shmakov D Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):431-7. PubMed ID: 23647125 [TBL] [Abstract][Full Text] [Related]
33. [Heart hypertrophy and heart failure--experimental findings for arrhythmogenesis]. Milberg P; Pott C; Eckardt L; Breithardt G Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S285-9. PubMed ID: 19085808 [TBL] [Abstract][Full Text] [Related]
34. Age is a risk factor for maladaptive changes in rats exposed to increased pressure loading of the right ventricular myocardium. Vida VL; Angelini A; Ausoni S; Bilardi A; Ori C; Vlassich F; Zoso V; Milanesi O; Sartore S; della Barbera M; Zaglia T; Thiene G; Stellin G Cardiol Young; 2007 Apr; 17(2):202-11. PubMed ID: 17381884 [TBL] [Abstract][Full Text] [Related]
35. Uni- or bi-ventricular hypertrophy and susceptibility to drug-induced torsades de pointes. Panyasing Y; Kijtawornrat A; Del Rio C; Carnes C; Hamlin RL J Pharmacol Toxicol Methods; 2010; 62(2):148-56. PubMed ID: 20435152 [TBL] [Abstract][Full Text] [Related]
36. [Prognostic factors after sustained ventricular fibrillation or tachycardia. A multivariate study apropos of 160 cases]. Fleurant E; Lacroix D; Klug D; Warembourg H; Kacet S; Lekieffre J Arch Mal Coeur Vaiss; 1996 Apr; 89(4):435-44. PubMed ID: 8763003 [TBL] [Abstract][Full Text] [Related]
37. Right ventricular hypertrophy with early dysfunction: A proteomics study in a neonatal model. Sheikh AM; Barrett C; Villamizar N; Alzate O; Valente AM; Herlong JR; Craig D; Lodge A; Lawson J; Milano C; Jaggers J J Thorac Cardiovasc Surg; 2009 May; 137(5):1146-53. PubMed ID: 19379982 [TBL] [Abstract][Full Text] [Related]
38. Wall stress induced arrhythmia is enhanced by low potassium and early left ventricular hypertrophy in the working rat heart. Evans SJ; Levi AJ; Jones JV Cardiovasc Res; 1995 Apr; 29(4):555-62. PubMed ID: 7796450 [TBL] [Abstract][Full Text] [Related]
39. Downregulation of Kv4.2 and Kv4.3 channel gene expression in right ventricular hypertrophy induced by monocrotaline in rat. Zhang TT; Cui B; Dai DZ Acta Pharmacol Sin; 2004 Feb; 25(2):226-30. PubMed ID: 14769214 [TBL] [Abstract][Full Text] [Related]